Carregant...
Combating Intracellular Pathogens with Repurposed Host-Targeted Drugs
There is a large, global unmet need for the development of countermeasures to combat intracellular pathogens. The development of novel antimicrobials is expensive and slow and typically focuses on selective inhibition of proteins encoded by a single pathogen, thereby providing a narrow spectrum of c...
Guardat en:
| Publicat a: | ACS Infect Dis |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Chemical Society
2018
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5807128/ https://ncbi.nlm.nih.gov/pubmed/29298032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsinfecdis.7b00268 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|